Pharmaceuticals
Alternative labels
Medication
Pharmaceutical industry
Briefing paper
The impact of Australian hospital medicines funding on achieving the objectives of the National Medicines Policy
In Australia, the National Medicines Policy (NMP) provides a framework for the way we use medicines across our health services with an aim to deliver medicines and related services while achieving optimal health outcomes and value. The policy identifies key objectives to achieve its aim: the quality use of medicines; access to cost-effective medicines’ medicines...
Position paper
The opioid crisis in North America
North America is facing an epidemic of opioid addiction and opioid overdose with an unprecedented level of mortality. The crisis was spurred by a broad expansion of medical use of opioids, which began in the 1990s as a legitimate response to the under-treatment of pain, but which was soon exploited by the unethical behavior of...
Briefing paper
Anti-retroviral therapy and social danger in Papua New Guinea
Reports new ways that anti-retroviral therapy in Papua New Guinea is being refracted through Christian moral discourses.
Report
State of the sector: medical technologies and pharmaceuticals 2017
Australia is one of the world’s leading locations for the development and manufacture of medical technologies, biotechnologies and pharmaceuticals. This report demonstrates that the sector’s economic impact is significant and positive.
Report
State of the sector: medical technologies and pharmaceuticals 2017
There is a lot of economic opportunity for Victorian companies to develop and manufacture new drugs, devices and digital health solutions that will shape the future of healthcare.